Ascorbic acid-pretreated quartz enhances cyclo-oxygenase-2 expression in RAW 264.7 murine macrophages.

Exposure to quartz particles induces a pathological process named silicosis. Alveolar macrophages initiate the disease through their activation, which is the origin of the later dysfunctions. Ascorbic acid is known to selectively dissolve the quartz surface. During the reaction, ascorbic acid progressively disappears and hydroxyl radicals are generated from the quartz surface. These observations may be relevant to mammalian quartz toxicity, as substantial amounts of ascorbic acid are present in the lung epithelium. We studied the inflammatory response of the murine macrophage cell line RAW 264.7 incubated with ascorbic acid-treated quartz, through the expression and activity of the enzyme cyclo-oxygenase-2 (COX-2). COX-2 expression and prostaglandin secretion were enhanced in cells incubated with ascorbic acid-treated quartz. In contrast, no changes were observed in cells incubated with Aerosil OX50, an amorphous form of silica. Quantification of COX-2 mRNA showed a threefold increase in cells incubated with ascorbic acid-treated quartz compared with controls. The transcription factors, NF-kappaB, pCREB and AP-1, were all implicated in the increased inflammatory response. Reactive oxygen species (H(2)O(2) and OH(*)) were involved in COX-2 expression in this experimental model. Parallel experiments performed on rat alveolar macrophages from bronchoalveolar lavage confirmed the enhanced COX-2 expression and activity in the cells incubated with ascorbic acid-treated quartz compared with untreated quartz. In conclusion, the selective interaction with, and modification of, quartz particles by ascorbic acid may be a crucial event determining the inflammatory response of macrophages, which may subsequently develop into acute inflammation, eventually leading to the chronic pulmonary disease silicosis.

Selective inhibition of inducible cyclo-oxygenase-2 expression by antisense peptide nucleic acids in intact murine macrophages.

Prostaglandins are important molecules involved in inflammation and immunomodulation. The rate-limiting step in the synthesis of these potent mediators is the expression of the enzyme cyclo-oxygenase (COX). The isoform responsible, COX-2, is encoded by an immediate-early gene induced by various pro-inflammatory agents in macrophages. Selective blockade of COX-2 by the use of an antisense strategy would overcome the undesirable side effects of conventional inhibitors. Here we describe cellular internalization and activity of a novel class of oligonucleotide analogues named peptide nucleic acids (PNAs) as inhibitors of COX-2 translation. In particular, we designed two antisense murine COX-2 PNA molecules, directed against a mRNA region spanning the AUG translation-initiation codon and a homopurinic sequence inside the COX-2 mRNA reading frame. These two PNA sequences, used separately or mixed together, demonstrated the capacity to inhibit the translation of murine COX-2 enzyme in a cell-free translation model using a rabbit retculocyte lysate model. Since PNAs display very low natural permeability across lipids bilayers, the two molecules were also re-synthesized, modified to be used in intact cells by means of linkage to a hydrophobic peptide to obtain membrane-diffusable PNA chimaerae. Finally, stimulated macrophages were found to be affected strongly by these two compounds, used separately or together, monitoring inhibition of COX-2 synthesis by Western blot analysis of total lysates and enzymic activity via radioactive assay on the microsomal fractions.

Inhibition of macrophage iNOS by selective targeting of antisense PNA.

Peptide nucleic acids (PNAs) are synthetic polynucleobases that bind to DNA and RNA with high affinity and specificity and with poor membrane permeability. Although PNAs have an enormous potential as antisense agents, the success of antisense PNA applications will require efficient cellular uptake. In this study, a unique antisense 14-mer anti-inducible nitric oxide synthase (iNOS) was encapsulated into erythrocytes (RBC) by hypotonic dialysis. RBC loaded with PNA (10.5 +/- 3.5 micromol/mL RBC) were targeted specifically to murine macrophages, taking advantage of an in vitro opsonization induced by ZnCl(2) and bis-sulfosuccynimidil-suberate (BS(3)). This in vitro opsonization enhanced the phagocytosis of loaded RBC and the delivery of PNA into macrophages (0.72 pmol/10(6) macrophages). The efficacy of this delivery system is demonstrated by decreases in NO production and iNOS protein expression inside the macrophage. Therefore, we can suggest this novel approach for biomedical application.